Please Wait
Applying Filters...
menu
    • menu
    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Pirepemat

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    IRLAB Granted Patent For Pirepemat Expanding Patent Protection In The US
    IRLAB Granted Patent For Pirepemat Expanding Patent Protection In The US

    18 Sep 2024

    // ACCESSWIRE

    https://www.accesswire.com/919554/irlab-granted-additional-patent-for-its-drug-candidate-pirepemat-expanding-the-patent-protection-in-the-us

    ACCESSWIRE
    18 Sep 2024
    Share Share
    IRLAB's Phase IIb Study Of Pirepemat Proceeds After Positive Safety Review
    IRLAB's Phase IIb Study Of Pirepemat Proceeds After Positive Safety Review

    02 Jul 2024

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=884181&lang=en

    ACCESSWIRE
    02 Jul 2024
    Share Share
    IRLAB’s Phase IIb Study with Pirepemat - React-PD - Provides New Insights
    IRLAB’s Phase IIb Study with Pirepemat - React-PD - Provides New Insights

    06 Feb 2024

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=831422&lang=en

    ACCESSWIRE
    06 Feb 2024
    Share Share
    IRLAB is Granted Additional Patent for Drug Candidate Pirepemat
    IRLAB is Granted Additional Patent for Drug Candidate Pirepemat

    12 Dec 2023

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=815915&lang=en

    ACCESSWIRE
    12 Dec 2023
    Share Share